Table 1 Patient’s characteristics.
All patients | Percentage of capping | P-value | ||||
|---|---|---|---|---|---|---|
[0–10[ | [10–50[ | [50–90[ | [90–100] | |||
No. of patients (%) | 130 (100%) | 13 (10%) | 42 (32.3%) | 50 (38.5%) | 25 (19.2%) | |
Women, N (%) | 126 (96.9%) | 13 (100%) | 42 (100%) | 48 (96%) | 23 (92%) | 0.274 |
Age (years), median [Q1, Q3] | 57 [48–63] | 53 [48–60] | 53 [48–62] | 59 [50–65] | 55 [47–63] | 0.288 |
Weight (kg), median [Q1, Q3] | 99,5 [95–105] | 98 [93–103] | 98 [92,2-105] | 99.5 [95-102.8] | 102 [97–109] | |
BMI (kg/m2), median [Q1, Q3] | 35,8 [32.7–39.3] | 36,6 [33.3–37.8] | 35.5 [32.5–39.1] | 36,1 [32.1–38.9] | 37 [32.7–40.9] | 0.762 |
Menopausal patient, N (%) | 72 (55.4%) | 7 (53.8%) | 21 (50%) | 32 (64%) | 12 (48%) | 0.616 |
Concurrent pathologies, N (%) | 90 (69.2%) | 10 (76.9%) | 25 (59.5%) | 38 (76%) | 17 (68%) | 0.506 |
Cardiovascular diseases, N (%) | 80 (43%) | 9 (52.9%) | 18 (38.3%) | 35 (44.9%) | 18 (40.9%) | |
Diabetes, N (%) | 26 (14%) | 1 (5.9%) | 9 (19.1%) | 10 (12.8%) | 6 (13.6%) | |
Previous cancer (including breast cancer), N (%) | 20 (15.4%) | 3 (23.1%) | 10 (23.8%) | 5 (10%) | 2 (8%) | 0.169 |
Previous chemotherapy, N (%) | 10 (7.7%) | 0 (0%) | 5 (11.9%) | 3 (6%) | 2 (8%) | |
